The global airway clearance system market has witnessed significant growth in recent years, driven by factors such as increasing prevalence of respiratory diseases, technological advancements in ...

A unique feature of airway clearance methods using ventilatory support is the potential to enhance lung volumes and expiratory flow rates during circumstances where the respiratory system is ...

Inogen said regulators have cleared its SIMEOX 200 Airway Clearance Device to be used by U.S. patients with chronic respiratory diseases. The medical technology company said Monday that the Food ...

“By tapping into our well-established network of healthcare providers, B2B partners, and our Direct-to-Patient team, we aim to bring this next-generation airway clearance device to patients ...

Inogen, Inc. INGN recently announced the FDA 510(k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is likely to expand INGN’s ability to market the device and meet the ...

The addition of oscillations to PEP therapy has been proposed to enhance airway clearance by improving the viscoelastic properties of sputum. Favorable effects have been demonstrated using pulse ...

We are very excited to receive FDA clearance for the innovative SIMEOX 200 therapy for patients in the U.S.,” Kevin Smith, President and Chief Executive Officer, Inogen ...

(RTTNews) - Inogen, Inc. (INGN), Monday announced that the company has received U.S. Food and Drug Administration 510(k) clearance for the SIMEOX 200 Airway Clearance Device, designed to help ...